Lisondra, Novelyn .

HRN: 22-13-71  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
11/23/2023
11/30/2023
IV
120mg; 60mg
OD
Sepsis
Checking Final Appropriateness 

Indication:  ProphylaxisEmpiric    Type of Infection:  BloodstreamProphylaxis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: